JHM is committed to becoming a global leader in synthetic biology. Through continuous innovation, the company is broadening the applications of recombinant protein drugs and products in healthcare applications thereby creating exceptional value for human health.

“JHM not only focuses on technological innovation, but also patient needs. Through our team’s relentless efforts, we hope to provide safe, effective, and affordable treatments to a diverse set of patients, bringing health, beauty, and hope to all.”